Partner Fund Management L.P. 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
Partner Fund Management L.P. | 0 0.000% |
-2,742,936 (Position Closed) |
Filing |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | ESSA Pharma Inc. EPIX |
Partner Fund Management L.P. | 2,742,936 6.200% |
-519,564 (-15.93%) |
Filing |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
Partner Fund Management L.P. | 3,262,500 7.400% |
-581,832 (-15.13%) |
Filing |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Partner Fund Management L.P. | 3,844,332 8.700% |
0 (Unchanged) |
Filing |
| 2022-11-10 4:02 pm Purchase |
2022-10-31 | 13G | ESSA Pharma Inc. EPIX |
Partner Fund Management L.P. | 3,844,332 8.700% |
3,844,332 (New Position) |
Filing |